You are here: Industry Insights > Biologics

News List

FDA accepts Roche's supplemental biologics license application for Tecentriq plus chemotherapy (Abraxane and carboplatin) worldpharmanews
January 22, 2019
Roche announced that the US Food and Drug Administration has accepted the company's supplemental Biologics License Application for Tecentriq
AZ appoints controversial doctor to lead new oncology unit pharmaphorum
January 09, 2019
AstraZeneca has a new and controversial oncology head after the departure of two key leaders led to a management reshuffle....
Roquette & Thermo Fisher Enter Distribution Deal contractpharma
December 21, 2018
Roquette and Thermo Fisher Scientific have entered a distribution rights agreement for the Roquette portfolio of pharmaceutical ingredients in the United States and Canada to support the high growth potential in these markets.
FDA releases Guidance for Industry on Clinical Trial Endpoints for the Approval of Cancer Drugs and Biologics americanpharmaceuticalreview
December 20, 2018
FDA is announcing the availability of a revised guidance for industry entitled “Clinical Trial Endpoints for the Approval of Cancer Drugs and Biologics.”......
Lilly's Taltz beats out AbbVie's megadrug Humira in psoriatic arthritis showdown fiercepharma
December 19, 2018
What’s a surefire way to get noticed in any field? Beat out a behemoth. And that’s what Eli Lilly’s Taltz has just done in psoriatic arthritis (PsA).
WuXi Biologics, ABL Bio Enter Development Deal contractpharma
November 30, 2018
WuXi Biologics and ABL Bio Corporation have entered into an exclusive development and clinical manufacturing partnership for up to 8 antibody therapeutics including ABL Bio’s biologics pipelines and collaboration programs between...
WuXi Biologics Begins Construction of New Facility contractpharma
November 27, 2018
WuXi Biologics said that construction of a global innovation center has commenced in the district of Fengxian in Shanghai, China.
Cobra, Pall, Cell and Gene Therapy Catapult Win £1.5M Innovate UK Grant firstwordpharma
November 27, 2018
Cobra Biologics has won a £1.5m shared grant from Innovate UK, the United Kingdom’s innovation agency. Co-winners, Pall Corporation and the Cell and Gene Therapy Catapult will work
WuXi Biologics to Build New Biologics Center contractpharma
November 01, 2018
WuXi Biologics to Build New Biologics Center
Mylan, Fujifilm Kyowa Kirin Biologics Receive European Marketing Authorization for Hulio americanpharmaceuticalreview
September 21, 2018
Mylan and Fujifilm Kyowa Kirin Biologics announced the European Commission (EC) has granted marketing authorization for Hulio, a biosimilar to AbbVie's Humira (adalimumab), for all indications.

Previous page 1 2 3 4 5 6 7 8 9 Next page